173 Results
“If I receive funding as part of a multiple-PI application, do I lose my new PI status?”
Funding News Edition: May 15, 2024
Know Your Timeline to Award If All Goes According to Plan
Funding News Edition: January 17, 2024
Knowing when NIAID will begin funding your project is essential—it’s necessary for hiring support staff or arranging subcontracts or even timing a renewal application.

Don’t Waste Your Time: Take an Extra Minute When Selecting NOFOs, Form Sets
Funding News Edition: December 4, 2024
We’ve now reached a stretch of time in which two form sets (i.e., FORMS-H and FORMS-I) and two versions of certain notices of funding opportunities (NOFOs) will be active simultaneously.

FORMS-I Transition: Setting Up Dominoes to Topple on January 25, 2025
Funding News Edition: April 17, 2024
NIH will transition to FORMS-I for application due dates on or after January 25, 2025, and also implement new policies and procedures that accompany the switch.

Addressing Common Misconceptions About NOSIs
Funding News Edition: May 1, 2024
NIH uses notices of special interest (NOSIs) to invite applications on high-priority and high-opportunity areas of science. NOSIs are designed to reduce administrative burden on NIH staff and grant applicants alike.
Where to Check in an Opportunity for the Earliest Start Date
Funding News Edition: June 5, 2024
Most notices of funding opportunities list the application due date, peer review date, Advisory Council round, and earliest project start date in the “Key Dates” section of Part 1. Overview Information.
Ease Educational Debt Through Loan Repayment Programs
Funding News Edition: August 7, 2024
To be eligible, you must be a doctoral-level clinician or researcher who’s committed to conducting NIH-qualified clinical research. If NIH approves your application, we will repay up to $50,000 each year toward your qualified educational debt.
News Briefs and Worth Repeating
Funding News Edition: October 2, 2024
Reminder of NIH Policy on Late Applications Caused by Weather Emergencies; Examine Data on Professional Degree Types in NIH’s Grant Portfolio; NIH Revises Its Definition of Sexual and Gender Minority Populations
Don’t Get Spooked—Check the Grant Number for Unfunded Notifications
Funding News Edition: October 16, 2024
If you or your institution receives a notification alerting you that a change was made to your application status, pay attention to the grant application number referenced in the message.
Competing Revisions and How They Differ from Administrative Supplements
Funding News Edition: April 3, 2024
A competing revision provides additional funding for activities that call for an expansion of your original scope of award, whereas administrative supplements fund activities that, while unforeseen when the application was being submitted, are still within the scope of the project.
Conduct Translational Exploratory Research on Chemical Countermeasures
Funding News Edition: November 20, 2024
Research civilian chemical medical countermeasures and novel treatment strategies to combat serious morbidity and mortality resulting from high consequence public health chemical emergencies.
Understand Clinical Trials to Choose the Right Funding Opportunity
Funding News Edition: February 21, 2024
NIH defines a clinical trial as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.
Develop Tools to Tackle Antibiotic-Resistant Gram-Negative Bacteria
Funding News Edition: May 15, 2024
This opportunity will support milestone-driven projects focused on developing novel predictive models, assays, tools, or platforms aimed at gaining a better understanding of the rules and compound properties that govern the penetration and efflux of drug-like small molecules into Gram-negative bacterial pathogens.
Request Funding to Explore Controlled Release of HIV Vaccines
Funding News Edition: May 1, 2024
Conduct product-focused research to advance controlled-release vaccine strategies shown to improve immune responses for HIV prevention, treatment, and cure, and also to develop simplified or single-shot vaccination formulations.
Explore Mechanisms of Adverse Health Effects on the Nervous System After Toxic Chemical Exposure
Funding News Edition: December 4, 2024
Propose research on the fundamental mechanisms of toxicity of highly toxic Chemicals of Concern but also on potential new targets to inform the development of medical countermeasures that would be effective during and after civilian mass exposure situations.
Organize Meetings for the Chemical Countermeasures Research Program
Funding News Edition: October 2, 2024
Apply to organize a series of annual in-person scientific meetings, conferences, symposia, and workshops to advance innovations in therapeutic and chemical toxicology research.
For Ancillary Studies, Consider NIH Definitions Carefully
Funding News Edition: June 20, 2024
An ancillary study is an independent research project that uses samples or data from a parent study to extend knowledge in scientific areas beyond the original scope of the parent study. It may qualify as a clinical study or a clinical trial.
Develop Diagnostics, Therapeutics, and Vaccines for Herpes Simplex Virus
Funding News Edition: May 15, 2024
Apply if you can further the development of new products to prevent herpes simplex virus infection and improve the diagnosis and treatment of patients living with herpes.
Small Business Research: Priority Funding Topics for 2025
Funding News Edition: August 7, 2024
NIH assembled a list of scientific priorities for small business awards that match the research interests of its institutes and centers, including NIAID.

Help Develop Long-Acting and Simplified HIV Treatments
Funding News Edition: December 18, 2024
NIAID will support the development of safe and effective long-acting/sustained release technologies to help prevent and treat HIV and related co-infections such as tuberculosis, hepatitis B, and hepatitis C.
Request Support to Study Inborn Errors of Immunity
Funding News Edition: April 17, 2024
Research the causes and mechanisms of inborn errors of immunity, enable early detection and molecular diagnosis, and support strategies to treat and cure these disorders.
Improve Understanding of Mechanisms, Biomarkers of Trained Immunity
Funding News Edition: February 21, 2024
Apply for research support to study basic mechanisms and biomarkers of trained immunity (i.e., innate immune memory), plus the functional implications of trained immunity.
Act Now for Funding to Establish T32 Training Slots for Data Science
Funding News Edition: September 4, 2024
Predoctoral trainees should become capable of applying data science methods and technologies across infectious and immune-mediated diseases research domains.
Contact Us
Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.